NEW AND EXPANDED!!!
3rd Edition (2015)
This Third Edition expands and amplifies the research and new information on Beta Glucan and how it can assist the body's immune system. It highlights 20 years of research by Vaclav Vetvicka, Ph.D. of Louisville, Ky. B-D-glucans belong to a group of physiologically active compounds called "biological response modifiers" and represent highly conserved structural components of cell walls in yeast, fungi, and seaweed. Glucans stimulate the immune system, but do not overstimulate it to the point where it becomes overactive, and so may be highly effective in such auto-immune illness as lupus, multiple sclerosis, rheumatoid arthritis, allergies, and yeast infections.
Since the first direct scientific studies, countless animal and human trials have shown remarkable anti-tumor activity against a wide range of different tumors including breast, lung, and gastrointestinal cancer.
In Japan, beta glucan is already licensed as an immunostimulant effective in cancer treatment. Two types of beta glucan have been used successfully since the 1980s as traditional medicine for cancer therapy in Japan and China. In addition, numerous clinical trials are currently under way, both in the United States and in several European countries.
However, beta glucan has much more to offer and can be beneficial against:
Irradiation and/or chemotherapy
Nonspecific stimulation of defense reactions
About the Author
Vaclav Vetvicka, Ph.D., is Professor of Pathology in the Department of Pathology of the University of Louisville in Louisville, KY. He graduated from Charles University in Prague, Czech Republic, with an advanced degree in biology and obtained his Ph.D. from the Czechoslovak Academy of Sciences. His postgraduate training included a stay at the Oklahoma Medical Research Foundation, Oklahoma City, and at the Institute of Microbiology, Prague, Czech Republic. His main area of research interest focuses on the development of natural immunomodulators.
In addition to the glucan research, Dr. Vetvicka helped to launch glucan in several countries including USA, France, Turkey and Czech Republic. Dr. Vetvicka is author and co-author of more than 220 peer-reviewed publications, seven books and five international patents.